Carriers of single pathogenic variants of the CFTR (cystic fibrosis transmembrane conductance regulator) gene have a higher risk of severe COVID-19 and 14-day death. The machine learning post-Mendelian model pinpointed CFTR as a bidirectional modulator of COVID-19 outcomes. Here, we demonstrate that the rare complex allele [G576V;R668C] is associated with a milder disease via a gain-of-function mechanism. Conversely, CFTR ultra-rare alleles with reduced function are associated with disease severity either alone (dominant disorder) or with another hypomorphic allele in the second chromosome (recessive disorder) with a global residual CFTR activity between 50 to 91%. Furthermore, we characterized novel CFTR complex alleles, including [A238V;F508del], [R74W;D1270N;V201M], [I1027T;F508del], [I506V;D1168G], and simple alleles, including R347C, F1052V, Y625N, I328V, K68E, A309D, A252T, G542*, V562I, R1066H, I506V, I807M, which lead to a reduced CFTR function and thus, to more severe COVID-19. In conclusion, CFTR genetic analysis is an important tool in identifying patients at risk of severe COVID-19.

Baldassarri, M., Zguro, K., Tomati, V., Pastorino, C., Fava, F., Croci, S., et al. (2022). Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes. CELLS, 11(24), 4096 [10.3390/cells11244096].

Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes

Baldassarri, Margherita;Zguro, Kristina;Fava, Francesca;Croci, Susanna;Bruttini, Mirella;Renieri, Alessandra;Fallerini, Chiara;Francesca Mari
Membro del Collaboration Group
;
Sergio Daga
Membro del Collaboration Group
;
Ilaria Meloni
Membro del Collaboration Group
;
Diana Alaverdian
Membro del Collaboration Group
;
Giada Beligni
Membro del Collaboration Group
;
Debora Maffeo
Membro del Collaboration Group
;
Elena Pasquinelli
Membro del Collaboration Group
;
Loredaria Adamo
Membro del Collaboration Group
;
Viola Bianca Serio
Membro del Collaboration Group
;
Enrica Antolini
Membro del Collaboration Group
;
Giulia Brunelli
Membro del Collaboration Group
;
Caterina Lo Rizzo
Membro del Collaboration Group
;
Anna Maria Pinto
Membro del Collaboration Group
;
Francesca Ariani
Membro del Collaboration Group
;
Francesca Montagnani
Membro del Collaboration Group
;
Mario Tumbarello
Membro del Collaboration Group
;
Massimiliano Fabbiani;Elena Bargagli
Membro del Collaboration Group
;
Laura Bergantini
Membro del Collaboration Group
;
Miriana D'Alessandro
Membro del Collaboration Group
;
Paolo Cameli
Membro del Collaboration Group
;
David Bennett
Membro del Collaboration Group
;
Federico Anedda
Membro del Collaboration Group
;
Simona Marcantonio
Membro del Collaboration Group
;
Sabino Scolletta
Membro del Collaboration Group
;
Federico Franchi
Membro del Collaboration Group
;
Maria Antonietta Mazzei
Membro del Collaboration Group
;
Susanna Guerrini
Membro del Collaboration Group
;
Edoardo Conticini
Membro del Collaboration Group
;
Luca Cantarini
Membro del Collaboration Group
;
Bruno Frediani
Membro del Collaboration Group
;
Serafina Valente
Membro del Collaboration Group
;
Alessia Giorli
Membro del Collaboration Group
;
Lorenzo Salerni
Membro del Collaboration Group
;
Marco Gori
Membro del Collaboration Group
;
Roberto Leoncini
Membro del Collaboration Group
;
2022-01-01

Abstract

Carriers of single pathogenic variants of the CFTR (cystic fibrosis transmembrane conductance regulator) gene have a higher risk of severe COVID-19 and 14-day death. The machine learning post-Mendelian model pinpointed CFTR as a bidirectional modulator of COVID-19 outcomes. Here, we demonstrate that the rare complex allele [G576V;R668C] is associated with a milder disease via a gain-of-function mechanism. Conversely, CFTR ultra-rare alleles with reduced function are associated with disease severity either alone (dominant disorder) or with another hypomorphic allele in the second chromosome (recessive disorder) with a global residual CFTR activity between 50 to 91%. Furthermore, we characterized novel CFTR complex alleles, including [A238V;F508del], [R74W;D1270N;V201M], [I1027T;F508del], [I506V;D1168G], and simple alleles, including R347C, F1052V, Y625N, I328V, K68E, A309D, A252T, G542*, V562I, R1066H, I506V, I807M, which lead to a reduced CFTR function and thus, to more severe COVID-19. In conclusion, CFTR genetic analysis is an important tool in identifying patients at risk of severe COVID-19.
2022
Baldassarri, M., Zguro, K., Tomati, V., Pastorino, C., Fava, F., Croci, S., et al. (2022). Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes. CELLS, 11(24), 4096 [10.3390/cells11244096].
File in questo prodotto:
File Dimensione Formato  
Gain- and Loss-of-Function CFTR-Baldassarri-2022.pdf

accesso aperto

Descrizione: Articolo
Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 4.46 MB
Formato Adobe PDF
4.46 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1223537